The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September. The parties intend to produce over 300 million doses of the vaccine in India per year, said RFID, Russia’s sovereign wealth fund that markets the vaccine globally. Serum Institute of India (SII) will begin production of the Russian-made Coronavirus disease (COVID-19) vaccine, Sputnik V, in September, with an annual production capacity of 300 million vaccine doses, the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund that markets the vaccine globally, announced on Tuesday.